InsuLife

InsuLife is a Norwegian biotechnology company dedicated to revolutionizing diabetes care through the development of needle-free insulin delivery systems. The company's lead product candidate, ILS-2501 (formerly known as Levellor), is a transdermal spray designed to deliver recombinant human insulin through the skin. By utilizing its proprietary Transdermal Delivery System (TDS) technology, InsuLife aims to eliminate the need for daily subcutaneous injections, thereby improving patient compliance and overall quality of life. The company has successfully conducted pilot clinical studies and is currently advancing towards formal Phase 1 clinical trials. InsuLife follows a lean development model, leveraging strategic partnerships for manufacturing and laboratory analysis. Its ultimate mission is to provide a painless and accessible insulin alternative for the growing global population of people living with diabetes.